DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer
Clinical trial NCT06077500 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06077500
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-14
- Primary completion
- 2026-09-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.